Skip to main content
. 2021 Dec 17;2(6Part B):733–741. doi: 10.1016/j.hroo.2021.08.008

Figure 3.

Figure 3

Effects of dantrolene (Dan) on ejection fraction following doxorubicin (Dox) treatment. Ejection fraction was measured by echocardiography in the 4 groups at 2 and 4 weeks following Dox treatment as described in Methods section. Asterisk (∗) denotes significant difference vs controls (P < .0001 at 2 weeks and P = .006 at 4 weeks) and ¥ denotes significant difference vs Dox only group (P < .0001 at 2 weeks and P = .002 at 4 weeks). N = 4–5 mice per group.